These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37947344)

  • 1. Modulation of functional networks related to the serotonin neurotransmitter system by citalopram: Evidence from a multimodal neuroimaging study.
    Boucherie DE; Reneman L; Booij J; Martins D; Dipasquale O; Schrantee A
    J Psychopharmacol; 2023 Dec; 37(12):1209-1217. PubMed ID: 37947344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity.
    Schrantee A; Lucassen PJ; Booij J; Reneman L
    Eur Neuropsychopharmacol; 2018 Oct; 28(10):1173-1179. PubMed ID: 30082141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging.
    Gryglewski G; Klöbl M; Berroterán-Infante N; Rischka L; Balber T; Vanicek T; Pichler V; Kautzky A; Klebermass EM; Reed MB; Vraka C; Hienert M; James GM; Silberbauer L; Godbersen GM; Unterholzner J; Michenthaler P; Hartenbach M; Winkler-Pjrek E; Wadsak W; Mitterhauser M; Hahn A; Hacker M; Kasper S; Lanzenberger R
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):711-719. PubMed ID: 31076187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
    Meyer JH; Wilson AA; Sagrati S; Hussey D; Carella A; Potter WZ; Ginovart N; Spencer EP; Cheok A; Houle S
    Am J Psychiatry; 2004 May; 161(5):826-35. PubMed ID: 15121647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.
    Voineskos AN; Wilson AA; Boovariwala A; Sagrati S; Houle S; Rusjan P; Sokolov S; Spencer EP; Ginovart N; Meyer JH
    Psychopharmacology (Berl); 2007 Sep; 193(4):539-45. PubMed ID: 17497139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
    de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
    Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study.
    Schrantee A; Solleveld MM; Schwantje H; Bruin WB; Mutsaerts HM; Adriaanse SM; Lucassen P; Booij J; Reneman L
    J Psychopharmacol; 2019 Jun; 33(6):660-669. PubMed ID: 30887865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats.
    Oosting RS; Chan JS; Olivier B; Banerjee P; Choi YK; Tarazi F
    Psychopharmacology (Berl); 2016 Mar; 233(6):1025-34. PubMed ID: 26758283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression.
    Smith GS; Kuwabara H; Gould NF; Nassery N; Savonenko A; Joo JH; Bigos KL; Kraut M; Brasic J; Holt DP; Hall AW; Mathews WB; Dannals RF; Nandi A; Workman CI
    Neuropharmacology; 2021 Aug; 194():108447. PubMed ID: 33450276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA.
    Dipasquale O; Selvaggi P; Veronese M; Gabay AS; Turkheimer F; Mehta MA
    Neuroimage; 2019 Jul; 195():252-260. PubMed ID: 30953835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic variation in 5-HTTLPR and the effects of citalopram on the emotional neural network.
    Ma Y; Li B; Wang C; Zhang W; Rao Y; Han S
    Br J Psychiatry; 2015 May; 206(5):385-92. PubMed ID: 25745133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study.
    Finnema SJ; Halldin C; Bang-Andersen B; Bundgaard C; Farde L
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4159-67. PubMed ID: 25980484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study.
    Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
    Aust N Z J Psychiatry; 2014 Dec; 48(12):1115-25. PubMed ID: 24810870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study.
    Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
    J Affect Disord; 2016 May; 196():11-9. PubMed ID: 26896742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
    Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
    Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder.
    Stengler-Wenzke K; Müller U; Barthel H; Angermeyer MC; Sabri O; Hesse S
    Neuropsychobiology; 2006; 53(1):40-5. PubMed ID: 16397403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram.
    Lundberg J; Christophersen JS; Petersen KB; Loft H; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):777-85. PubMed ID: 17201996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring endogenous changes in serotonergic neurotransmission with [
    da Cunha-Bang S; Ettrup A; Mc Mahon B; Skibsted AP; Schain M; Lehel S; Dyssegaard A; Jørgensen LM; Møller K; Gillings N; Svarer C; Knudsen GM
    Transl Psychiatry; 2019 Apr; 9(1):134. PubMed ID: 30975977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential serotonin transporter (5-HTT) and 5-HT
    Brandenburg C; Blatt GJ
    J Neurochem; 2019 Dec; 151(5):642-655. PubMed ID: 31325179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.